Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
Acq. announced
Director departure
Appointed director
ORE PHARMACEUTICAL HOLDINGS INC. (ORXE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2009 8-K Quarterly results
Docs: "Second Quarter 2009 Financial Results Reported"
02/26/2009 8-K Quarterly results
Docs: "Strategic Re-alignment Continues - Fourth Quarter 2008 Financial Results Reported"
02/29/2008 8-K Asset disposition, Quarterly results
Docs: "Ore Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results Drug Repositioning and Development Now Company Focus"
10/25/2007 8-K Quarterly results
Docs: "Gene Logic Reports Third Quarter 2007 Financial Results"
08/02/2007 8-K Quarterly results
Docs: "Gene Logic Reports Second Quarter 2007 Financial Results"
02/28/2007 8-K Quarterly results
Docs: "SECTION 2. FINANCIAL INFORMATION",
"Gene Logic Reports Fourth Quarter and Full Year 2006 Financial Results"
11/15/2006 8-K Quarterly results
Docs: "LOGIC INC. EXHIBIT 99.1"
08/04/2006 8-K Quarterly results
Docs: "Gene Logic Reports Second Quarter 2006 Financial Results"
04/21/2006 8-K Quarterly results
Docs: "Gene Logic Reports First Quarter 2006 Financial Results; Outlook Remains Strong, Guidance Confirmed; Drug Repositioning Partnerships Expanded",
"Gene Logic and Organon Enter Collaboration to Find New Therapeutic Applications for Clinical Drug Candidates"
02/24/2006 8-K Quarterly results
Docs: "Gene Logic Reports Fourth Quarter and Full Year 2005 Financial Results; Record Quarterly and Annual Revenue; Fourth Quarter Net Loss Narrows by 47%; Genomics Services Achieves Profitability for Fourth Consecutive Quarter"
10/28/2005 8-K Quarterly results
Docs: "Gene Logic Reports Third Quarter 2005 Financial Results; Signs Drug Repositioning Agreement with Pfizer; Achieves Profitability in Genomics Business for Third Consecutive Quarter; Updates Financial Guidance"
07/20/2005 8-K Quarterly results
Docs: "Gene Logic Reports Second Quarter 2005 Financial Results; Net Loss Narrows by 41%; Genomics Achieves Profitability for Second Consecutive Quarter; Drug Repositioning Adds 10 New Candidates to Pipeline, Advances 2 to Animal Model Validation"
04/22/2005 8-K Quarterly results
Docs: "SECTION 2. FINANCIAL INFORMATION",
"Gene Logic Reports First Quarter 2005 Financial Results; Net Loss Narrows by 26%, Genomics Achieves Profitability"
02/18/2005 8-K Quarterly results
Docs: "Gene Logic Reports Fourth Quarter and Full Year 2004 Financial Results"
10/22/2004 8-K Quarterly results
Docs: "LOGIC INC. EXHIBIT 99.1"
07/23/2004 8-K Quarterly results
Docs: "Gene Logic Reports Second Quarter 2004 Results"
04/23/2004 8-K Quarterly results
Docs: "Gene Logic Reports First Quarter 2004 Results; Record Revenue of $20.2 Million; Operating Loss Improves 12%; EPS Improves 14%"
03/02/2004 8-K Quarterly results
Docs: "Gene Logic Reports Fourth Quarter and Year End 2003 Results"
07/29/2003 8-K Quarterly results
Docs: "For further information, please contact:"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy